Metabolic syndrome is a cluster of metabolic indicators that increase the risk of diabetes and
cardiovascular diseases. Visceral obesity and factors derived from altered adipose tissue …

The metabolic syndrome (MetS), first introduced by Haller in 1975, was sometimes also
known as insulin resistance syndrome, syndrome X, and plurimetabolic syndrome. In 1989 …

BACKGROUND: Obesity associated insulin resistance is a major risk factor for type 2
diabetes mellitus. Resistin is recently reported to provide a link between obesity, insulin …

The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD)
continues to rise, making it one of the most prevalent chronic liver disorders. MASLD …

Biomarkers of the metabolic syndrome are divided into four subgroups. Although dividing
them in groups has some limitations, it can be used to draw some conclusions. In a first part …

Metabolic syndrome (MetS) has a collection of some abnormal and pathological conditions
that cause many critical diseases. Resistin is one of the possible candidates for these …

Aims: The serum resistin level is associated with the incidence of ischemic heart disease in
the general population. We analyzed the associations between serum resistin and fat intake …

Aims There is increasing evidence linking a shift work schedule with various adverse health
effects. The present study aimed to examine the relationship between shift work and the …

Resistin has been implicated in coronary atherosclerotic disease and congestive heart
failure. Recent studies have extended its involvement in peripheral artery disease. Despite …

With aging, an increased prevalence of a clustering of metabolic abnormalities has been
observed. These abnormalities include obesity, dyslipidemia, hypertension, and insulin …